Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-DTBZ PET Imaging in Parkinson's Disease
NCT01759888Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Aug 2011
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Florbenazine F-18 in Parkinson's disease (PD), sponsored by Chang Gung Memorial Hospital. Started Aug 2011; status: completed.
02
Drugs
Florbenazine F-18
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01759888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01759888.